major depressive disorder

Praxis wields the axe as lead depression drug fails
Pharmaforum
Tue, 06/7/22 - 10:12 am
Praxis Precision Medicines
major depressive disorder
layoffs
restructuring
PRAX-114
Sage, Biogen get rolling on FDA submission for depression med
Fierce Biotech
Mon, 05/2/22 - 11:52 am
SAGE Therapeutics
Biogen
zuranolone
FDA
major depressive disorder
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
Endpoints
Wed, 02/23/22 - 10:24 pm
AbbVie
Vraylar
Allergan
major depressive disorder
FDA
AbbVie submits sNDA to FDA for major depressive disorder therapy
Pharmaceutical Business Review
Wed, 02/23/22 - 10:18 am
AbbVie
FDA
cariprazine
major depressive disorder
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
NASDAQ
Sat, 10/30/21 - 10:43 pm
AbbVie
clinical trials
cariprazine
major depressive disorder
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
BioSpace
Mon, 10/4/21 - 10:55 pm
Biogen
SAGE Therapeutics
major depressive disorder
postpartum depression
clinical trials
zuranolone
Letter from FDA outlining deficiencies for lead drug causes Axsome stock to crater. Is a CRL on the way?
Endpoints
Mon, 08/9/21 - 11:02 am
Axsome
major depressive disorder
FDA
AXS-05
Sage braces for make-or-break depression data
BioPharma Dive
Tue, 05/4/21 - 10:41 pm
SAGE Therapeutics
earnings
major depressive disorder
Zulresso
Otsuka and Click Therapeutics Tap Verily to Go Remote with Trial
Medical Devices and Diagnostics Industry
Sun, 02/28/21 - 11:58 pm
Otsuka
Click Therapeutics
major depressive disorder
clinical trials
Verily
remote clinical trials
Is Biogen Getting Desperate?
Motley Fool
Wed, 12/9/20 - 10:42 am
Biogen
SAGE Therapeutics
major depressive disorder
depression
Sage shares data on retreatment with depression drug zuranolone
Fierce Biotech
Thu, 10/15/20 - 12:02 pm
SAGE Therapeutics
zuranolone
clinical trials
major depressive disorder
FDA expands use of controversial J&J antidepressant
Beckers Hospital Review
Wed, 08/5/20 - 12:01 am
FDA
JNJ
Spravato
treatment-resistant depression
major depressive disorder
ketamine
Acadia fails in attempt to expand use of antipsychotic to treat patients with depression
Stat
Mon, 07/20/20 - 11:54 pm
Acadia Pharma
clinical trials
major depression
Nuplazid
major depressive disorder
antipsychotics
Presented with upbeat Alzheimer's agitation data, FDA sees another 'breakthrough' in Axsome's AXS-05
Endpoints
Sat, 06/27/20 - 11:37 pm
Axsome Therapeutics
Alzheimer's disease
AXS-05
major depressive disorder
Sage to run 3 new studies to save once-failed depression drug
Fierce Biotech
Wed, 03/18/20 - 10:14 am
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
Here's Why Sage Therapeutics Lost 53.3% in December
Motley Fool
Mon, 01/6/20 - 11:28 pm
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
How Big of a Deal Is Axsome Therapeutics' New Depression Drug?
Motley Fool
Wed, 12/18/19 - 11:51 pm
Axsome Therapeutics
AXS-05
major depressive disorder
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Mon, 12/16/19 - 10:52 am
Axsome Therapeutics
AXS-05
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
major depressive disorder
Intra-Cellular Therapies
lumateperone
schizophrenia
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned
Xconomy
Mon, 12/16/19 - 10:38 am
Axsome Therapeutics
AXS-05
major depressive disorder
clinical trials
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Xconomy
Thu, 12/5/19 - 10:11 am
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder

Pages